<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02121951</url>
  </required_header>
  <id_info>
    <org_study_id>Quadratus Lumborum Block</org_study_id>
    <nct_id>NCT02121951</nct_id>
  </id_info>
  <brief_title>Quadratus Lumborum Block for Percutaneous Nephrostomy</brief_title>
  <acronym>QLB</acronym>
  <official_title>Quadratus Lumborum Block Versus Local Anesthetic Infiltration Combined With Monitored Anesthesia Care for Percutaneous Nephrostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Egypt</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous nephrostomy (PCN) is one of the interventions in the radiology department in
      which pain control is necessary. Quadratus Lumborum (QL) block will be tried to limit the use
      of systemic analgesics and its accompanying untoward effects in those frail patients
      requiring PCN that is performed in the prone position.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Quadratus Lumborum block is a novel technique in which extension into the thoracic
      paravertebral space may occur. QL block would seem to be able to alleviate both somatic and
      visceral pain so it's expected to decrease the need for systemic sedation\analgesia to a
      minimum.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia</measure>
    <time_frame>4 hours</time_frame>
    <description>Verbal Rating Scale is assessed for degree of pain during the procedure and after till discharge from the radiology department.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory Depression</measure>
    <time_frame>4 hours</time_frame>
    <description>Respiratory rate and airway patency is monitored with an anesthesiologist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>4 hours</time_frame>
    <description>Ramsay Seadation Score is assessed during and after procedure till discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular stability</measure>
    <time_frame>4 hours</time_frame>
    <description>Blood pressure and Heart rate is assessed during and after procedure till discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>48 hours</time_frame>
    <description>Patient Satisfaction Quistionaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Nephrostomy; Complications</condition>
  <condition>Upper Urinary Tract Dilatation and Obstruction</condition>
  <condition>Regional Anesthesia Morbidity</condition>
  <condition>Adverse Anesthesia Outcome</condition>
  <arm_group>
    <arm_group_label>Local Anesthetic infiltration and MAC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local Anesthetic infiltration with 1% lignocaine
MAC with IV Midazolam Img\ml and Fentanyl 10 mic\ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quadratus Lumborum block and MAC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>QL block with 0.25% levobupivacaine (Chirocaine, Abbott, Ireland) and 1% lignocaine
MAC with IV Midazolam Img\ml and Fentanyl 10 mic\ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local Anesthetic infiltration</intervention_name>
    <description>Lignocaine infiltration through the nephrostomy track</description>
    <arm_group_label>Local Anesthetic infiltration and MAC</arm_group_label>
    <other_name>Lignocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Quadratus Lumborum block</intervention_name>
    <description>A linear 12-MHz ultrasound probe will be placed in the anterior axillary line to visualize the typical triple abdominal layers. Then, the probe will be placed in the midaxillary line and at this point the layers of abdominal layers starte to taper. The probe will be placed in the posterior axillary line, sonoanatomy will show first the transversus abdominis disappearing then the internal oblique and external oblique forming aponeurosis and appearance of QL will be noticed. At the posterior border of the quadratus lumborum muscle and outside the fascia, Touhe needle will be inserted in plane and confirmed its position by injecting saline. Under ultrasound (US) guidance, local anesthetic mixure will be deposited separating the fascia</description>
    <arm_group_label>Quadratus Lumborum block and MAC</arm_group_label>
    <other_name>-0.25% levobupivacaine (Chirocaine, Abbott, Ireland)</other_name>
    <other_name>-1% lignocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MAC</intervention_name>
    <description>Incremental doses are given to the targed sedation and analgesia</description>
    <arm_group_label>Local Anesthetic infiltration and MAC</arm_group_label>
    <arm_group_label>Quadratus Lumborum block and MAC</arm_group_label>
    <other_name>-Midazolam: 1 mg\ml</other_name>
    <other_name>-Fentanyl: 10 mic\ml</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA grade III and IV patients,

          2. Ureteral obstruction due to malignancy or secondary to urinary diversion after
             cystectomy

        Exclusion Criteria:

          1. Bleeding diathesis; INR more than than 1.5 and platelet count less than 100,000/mm3.

          2. Untreated urinary tract infection;

          3. Pre-operative haemoglobin &lt;10 gm/dl,

          4. Severely co morbid patients

          5. Non-dilated renal collecting system

          6. Patient refusal to consent for the procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dina N Abbas, M D</last_name>
    <role>Study Director</role>
    <affiliation>National Cancer Institute, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ghada M Bashandy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wael Darwish, M D</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Institute, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Institute</name>
      <address>
        <city>Cairo</city>
        <state>Old Cairo</state>
        <zip>11796</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.respond2articles.com/ANA/forums/post/1550.aspx</url>
    <description>Optimal point of injection: The quadratus lumborum type I and II blocks</description>
  </link>
  <results_reference>
    <citation>Kadam VR. Ultrasound-guided quadratus lumborum block as a postoperative analgesic technique for laparotomy. J Anaesthesiol Clin Pharmacol. 2013 Oct;29(4):550-2. doi: 10.4103/0970-9185.119148.</citation>
    <PMID>24249997</PMID>
  </results_reference>
  <results_reference>
    <citation>Ironfield CM, Barrington MJ, Kluger R, Sites B. Are patients satisfied after peripheral nerve blockade? Results from an International Registry of Regional Anesthesia. Reg Anesth Pain Med. 2014 Jan-Feb;39(1):48-55. doi: 10.1097/AAP.0000000000000038.</citation>
    <PMID>24310051</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2014</study_first_submitted>
  <study_first_submitted_qc>April 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2014</study_first_posted>
  <last_update_submitted>April 8, 2018</last_update_submitted>
  <last_update_submitted_qc>April 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Egypt</investigator_affiliation>
    <investigator_full_name>Ghada M N Bashandy</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Percutaneous Nephrostomy</keyword>
  <keyword>Quadtatus Lumborum Block</keyword>
  <keyword>Cancer</keyword>
  <keyword>Monitored Anaesthesia Care</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

